June 2014

June 02, 2014

June 02, 2014

June 02, 2014

In this issue of Cardiology Review, we cover several burning topics of interest to clinicians.

June 02, 2014

The first wireless implantable hemodynamic monitoring system for patients with heart failure has been approved by the FDA.

June 02, 2014

The American Society of Hypertension (ASH) is the largest US professional organization dedicated to eradicating hypertension and its consequences. The following study presentations were highlights of the organization's 29th annual meeting in New York City.

June 02, 2014

June 02, 2014

AstraZeneca's Epanova (omega-3-carboxylic acids) was approved by the FDA for the treatment of adults with severe hypertriglyceridemia; two new studies support the concept that there can be too much of a good thing when it comes to exercise; and the FDA has issued a new statement recommending against the use of aspirin to prevent a first heart attack or stroke in people with no history of cardiovascular disease.

June 02, 2014

Mitral valve replacement provides a greater freedom from recurrent MR in patients with ischemic MR, but does it affect clinical outcomes?

June 02, 2014

The role of blood transfusions in patients undergoing percutaneous coronary intervention remains controversial.

June 02, 2014

Should we give digoxin another look for chronic heart failure?

June 02, 2014

The safety and efficacy of drug-eluting stents are proven in the general population, but how do they perform in women?

June 02, 2014

This meta-analysis attempts to definitively answer questions about the role of anger in cardiovascular events.

June 02, 2014

Access, delivery, and affordability-will the courts decide the best course of action or will Congress?

June 02, 2014

It is primarily the responsibility of parents, teachers, and health care professionals to be role models for the younger generation with respect to healthy eating and physical activity.